Cargando…

Correction: Recurrent Plasmodium falciparum Malaria Infections in Kenyan Children Diminish T-Cell Immunity to Epstein Barr Virus Lytic but Not Latent Antigens

Detalles Bibliográficos
Autores principales:	Snider, Cynthia J., Cole, Stephen R., Chelimo, Kiprotich, Sumba, Peter Odada, MacDonald, Pia D. M., John, Chandy C., Meshnick, Steven R., Moormann, Ann M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369808/ http://dx.doi.org/10.1371/annotation/87d81085-b796-4295-9468-030300d78cd6

Ejemplares similares

Recurrent Plasmodium falciparum Malaria Infections in Kenyan Children Diminish T-Cell Immunity to Epstein Barr Virus Lytic but Not Latent Antigens
por: Snider, Cynthia J., et al.
Publicado: (2012)

Age-Related Differences in Naturally Acquired T Cell Memory to Plasmodium falciparum Merozoite Surface Protein 1
por: Chelimo, Kiprotich, et al.
Publicado: (2011)

Activation of the Epstein–Barr virus lytic cycle by the latex of the plant Euphorbia tirucalli
por: MacNeil, A, et al.
Publicado: (2003)

Epstein–Barr Virus Genetic Variation in Lymphoblastoid Cell Lines Derived from Kenyan Pediatric Population
por: Simbiri, Kenneth O., et al.
Publicado: (2015)

Temporal stability of naturally acquired immunity to Merozoite Surface Protein-1 in Kenyan Adults
por: Dent, Arlene E, et al.
Publicado: (2009)

Decline in EBV-Specific IFN T cell responses in Kenyan infants from a malaria holoendemic region of Kenya
por: Asito, Amolo S, et al.
Publicado: (2012)

Interferon-gamma responses to Plasmodium falciparum liver-stage antigen-1 and merozoite-surface protein-1 increase with age in children in a malaria holoendemic area of western Kenya
por: Chelimo, Kiprotich, et al.
Publicado: (2003)

Human and Epstein-Barr Virus miRNA Profiling as Predictive Biomarkers for Endemic Burkitt Lymphoma
por: Oduor, Cliff I., et al.
Publicado: (2017)

Antibody-Mediated Growth Inhibition of Plasmodium falciparum: Relationship to Age and Protection from Parasitemia in Kenyan Children and Adults
por: Dent, Arlene E., et al.
Publicado: (2008)

ZEB1 Regulates the Latent-Lytic Switch in Infection by Epstein-Barr Virus
por: Yu, Xianming, et al.
Publicado: (2007)

The Dynamics of Naturally Acquired Immunity to Plasmodium falciparum Infection
por: Pinkevych, Mykola, et al.
Publicado: (2012)

Time-to-infection by Plasmodium falciparum is largely determined by random factors
por: Pinkevych, Mykola, et al.
Publicado: (2015)

Identification of a novel variant of LMP-1 of EBV in patients with endemic Burkitt lymphoma in western Kenya
por: Wohlford, Eric M, et al.
Publicado: (2013)

Epstein–Barr virus latent genes
por: Kang, Myung-Soo, et al.
Publicado: (2015)

Valpromide Inhibits Lytic Cycle Reactivation of Epstein-Barr Virus
por: Gorres, Kelly L., et al.
Publicado: (2016)

Inhibitory Effects of Resveratrol on the Epstein-Barr Virus Lytic Cycle
por: Yiu, Ching-Yi, et al.
Publicado: (2010)

Functional Implications of Epstein-Barr Virus Lytic Genes in Carcinogenesis
por: Yap, Lee Fah, et al.
Publicado: (2022)

Genetic variation in interleukin-7 is associated with a reduced erythropoietic response in Kenyan children infected with Plasmodium falciparum
por: Kisia, Lily E., et al.
Publicado: (2019)

Microgeographic variations in Burkitt's lymphoma incidence correlate with differences in malnutrition, malaria and Epstein–Barr virus
por: Sumba, P O, et al.
Publicado: (2010)

Epstein–Barr Virus: How Its Lytic Phase Contributes to Oncogenesis
por: Rosemarie, Quincy, et al.
Publicado: (2020)

Molecular Basis of Epstein–Barr Virus Latency Establishment and Lytic Reactivation
por: Murata, Takayuki, et al.
Publicado: (2021)

Rta is the principal activator of Epstein-Barr virus epithelial lytic transcription
por: Ali, Ahmed, et al.
Publicado: (2022)

Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesis
por: Li, Hongde, et al.
Publicado: (2016)

Inhibition of Epstein-Barr Virus Lytic Reactivation by the Atypical Antipsychotic Drug Clozapine
por: Anderson, Abbie G., et al.
Publicado: (2019)

Arsenicals, the Integrated Stress Response, and Epstein–Barr Virus Lytic Gene Expression
por: Lee, Jaeyeun, et al.
Publicado: (2021)

Replication Compartments—The Great Survival Strategy for Epstein–Barr Virus Lytic Replication
por: Sugimoto, Atsuko
Publicado: (2022)

Epstein-barr virus infected gastric adenocarcinoma expresses latent and lytic viral transcripts and has a distinct human gene expression profile
por: Tang, Weihua, et al.
Publicado: (2012)

Complexities associated with expression of Epstein–Barr virus (EBV) lytic origins of DNA replication
por: Xue, Shao-An, et al.
Publicado: (2007)

Parthenolide induces apoptosis and lytic cytotoxicity in Epstein-Barr virus-positive Burkitt lymphoma
por: LI, YUAN, et al.
Publicado: (2012)

Therapies based on targeting Epstein‐Barr virus lytic replication for EBV‐associated malignancies
por: Li, Hongde, et al.
Publicado: (2018)

A Temporal Proteomic Map of Epstein-Barr Virus Lytic Replication in B Cells
por: Ersing, Ina, et al.
Publicado: (2017)

Pseudouridylation of Epstein-Barr virus noncoding RNA EBER2 facilitates lytic replication
por: Henry, Belle A., et al.
Publicado: (2022)

The Dual Functions of Andrographolide in the Epstein–Barr Virus-Positive Head-and-Neck Cancer Cells: The Inhibition of Lytic Reactivation of the Epstein–Barr Virus and the Induction of Cell Death
por: Heawchaiyaphum, Chukkris, et al.
Publicado: (2023)

Autophagy-Dependent Reactivation of Epstein-Barr Virus Lytic Cycle and Combinatorial Effects of Autophagy-Dependent and Independent Lytic Inducers in Nasopharyngeal Carcinoma
por: Yiu, Stephanie Pei Tung, et al.
Publicado: (2019)

Inhibition of Poly(ADP-ribose)polymerase impairs Epstein Barr Virus lytic cycle progression
por: Mattiussi, Stefania, et al.
Publicado: (2007)

MCAF1 and synergistic activation of the transcription of Epstein–Barr virus lytic genes by Rta and Zta
por: Chang, Li-Kwan, et al.
Publicado: (2010)

The Immunomodulatory Capacity of an Epstein-Barr Virus Abortive Lytic Cycle: Potential Contribution to Viral Tumorigenesis
por: Morales-Sánchez, Abigail, et al.
Publicado: (2018)

Bromodomain and extraterminal inhibitors block the Epstein-Barr virus lytic cycle at two distinct steps
por: Keck, Kristin M., et al.
Publicado: (2017)

PARP1 restricts Epstein Barr Virus lytic reactivation by binding the BZLF1 promoter
por: Lupey-Green, Lena N., et al.
Publicado: (2017)

Lytic Induction Therapy against Epstein–Barr Virus-Associated Malignancies: Past, Present, and Future
por: Yiu, Stephanie Pei Tung, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2tm7qf1p8j57u07p6tf7klm6ln